SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-100755
Filing Date
2024-04-18
Accepted
2024-04-18 16:02:28
Documents
12
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d752944ddef14a.htm DEF 14A 419373
2 GRAPHIC g752944dsp2a.jpg GRAPHIC 1041
3 GRAPHIC g752944g41o23.jpg GRAPHIC 24843
4 GRAPHIC g752944g56o91.jpg GRAPHIC 35844
5 GRAPHIC g752944img1.jpg GRAPHIC 2877
6 GRAPHIC g752944img2.jpg GRAPHIC 29991
7 GRAPHIC g752944img3.jpg GRAPHIC 1540
8 GRAPHIC g752944img4.jpg GRAPHIC 1324
9 GRAPHIC g752944img5.jpg GRAPHIC 1299
10 GRAPHIC g752944img6.jpg GRAPHIC 1540
11 GRAPHIC g752944img7.jpg GRAPHIC 895
12 GRAPHIC g752944img8.jpg GRAPHIC 6094
  Complete submission text file 0001193125-24-100755.txt   565894
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40800 | Film No.: 24854287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)